Two year outcomes of EndoStim therapy presented at UEG Week in Berlin, Germany

Dr. Leonardo Rodriguez presented the 2 year outcomes of a single center long-term trial of EndoStim therapy for severe GERD. The featured study included 24 patients in Santiago, Chile; after 24 months of continuous EndoStim therapy, patients available for follow-up experienced sustained improvement in abnormal espophageal acid exposure, GERD symptoms, and elimination of PPI use between baseline and 24 month follow-up.


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.